Brief: DBP submits international PCT application for Temodex
04/05/2017 11:46
May 4 (Reuters) - DOUBLE BOND PHARMACEUTICAL INTERNATIONAL
AB (PUBL) DBPHAb.ST :
* SAYS SUBMITTED INTERNATIONAL PATENT COOPERATION TREATY
(PCT)APPLICATION FOR TEMODEX ON APRIL 28
* TEMODEX IS A TREATMENT FOR BRAIN CANCER
* THE APPLICATION WAS SUBMITTED TO SWEDISH PATENT AND
REGISTRATION OFFICE AND WILL LEAD TO FUTURE PATENT APPLICATIONS
ON KEY MARKETS
Source text: http://bit.ly/2q1jSbv
Further company coverage: DBPHAb.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University